-
Italy strengthens health-care rights for homeless people Lancet Public Health (IF 25.4) Pub Date : 2025-02-05 Emanuele Di Simone, Erika Renzi, Fabio Fabbian, Nicolò Panattoni, Azzurra Massimi
No Abstract
-
Mass incarceration as a key driver of gender disparities in tuberculosis Lancet Public Health (IF 25.4) Pub Date : 2025-02-05 Katherine C Horton, S Bertel Squire
We read with interest the article by Yiran Liu and colleagues assessing the contribution of mass incarceration to tuberculosis incidence in six Latin American countries.1 We welcome the attention that the authors bring to this important determinant of tuberculosis, yet we note that the authors do not mention the gendered dimension of this issue.
-
Correction to Lancet Public Health 2025; 10: e136–47 Lancet Public Health (IF 25.4) Pub Date : 2025-02-04
Global Burden of Disease US Health Disparities Collaborators. Life expectancy by county and educational attainment in the USA, 2000–19: an observational analysis. Lancet Public Health 2025; 10: e136–47—In this Article, the last sentence of the Summary, Findings should read “Over the study period, the gap in life expectancy between the college graduate population and those with less than a high-school
-
Cancer screening: putting people at the centre Lancet Public Health (IF 25.4) Pub Date : 2025-02-03
Feb 4 marks World Cancer Day—an opportunity to raise awareness about cancer and to reflect on the latest trends, challenges, and hopes. Acknowledging that cancer is not simply a medical diagnosis, but rather a unique personal story, the World Cancer Day campaign places people at the centre and calls for a people-centred approach to cancer.
-
Family-wide effects of adverse childhood experiences Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Nicole Racine, Shainur Premji
Exposure to adverse childhood experiences (ACEs), including abuse, neglect, and household challenges, have harmful implications for long-term health and mental health outcomes.1 Indeed, ACEs are one of the leading determinants of mental health disorders and are associated with increased health-care use into adulthood.1, 2 ACEs have the potential to infiltrate the family context, having implications
-
Does everyone benefit equally from physical activity? Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Mats Börjesson, Daniel Arvidsson
Regular physical activity is associated with a lower risk of cardiovascular disease and cancer, and with longevity.1 Studies on physical activity and health have initially been based on observational studies with small sample sizes.2 Nowadays, the study quality has improved and includes laboratory-based studies with controlled interventions, albeit with limited external validity, as well as longitudinal
-
Thank you to The Lancet Public Health's reviewers in 2024 Lancet Public Health (IF 25.4) Pub Date : 2025-02-03
No Abstract
-
Reflections on the tobacco-free generation: methodological challenges and global implications Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 A Sathiya Susuman
The study by Julia Rey Brandariz and colleagues1 provides a novel approach to estimating the effect of a tobacco-elimination strategy on lung-cancer mortality by projecting outcomes for a cohort born between 2006 and 2010 across 185 countries. Although this simulation study offers promising results, with the potential to prevent more than 40% of deaths from lung cancer in the cohort, several issues
-
Reflections on the tobacco-free generation: methodological challenges and global implications Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Sergi Trias-Llimós, Ariadna Feliu, Esteve Fernández
No Abstract
-
Reflections on the tobacco-free generation: methodological challenges and global implications – Authors’ reply Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Julia Rey Brandariz, Mónica Pérez-Ríos, Alberto Ruano-Ravina, Isabelle Soerjomataram
No Abstract
-
Correction to Lancet Public Health 2024; 9: e684–99 Lancet Public Health (IF 25.4) Pub Date : 2025-02-03
Macdonald C, Macpherson G, Leppan O, et al. Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis. Lancet Public Health 2024; 9: e684–99—In the Findings section of the Summary of this Article, the 95% CI in the second sentence should read “Therapeutic community interventions reduced re-arrest at 6–12 months (six studies; odds
-
Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Naomi Q P Tan, Renu S Nargund, Elisa E Douglas, Maria A Lopez-Olivo, Paul J Resong, Sayaka Ishizawa, Sara Nofal, Kate Krause, Robert J Volk, Iakovos Toumazis
BackgroundPersonalised risk-based screening (PRBS) can enhance the efficiency of cancer screening programnes, but little is known about support for its implementation among the general public and health-care professionals. We aimed to summarise the acceptability and perceptions of PRBS for breast, cervical, colorectal, lung, and prostate cancer screening among these groups. MethodsWe conducted a systematic
-
Prevalence of severe mental illness among people in prison across 43 countries: a systematic review and meta-analysis Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Christina Emilian, Noura Al-Juffali, Seena Fazel
BackgroundPrison populations have been increasing worldwide. Previous studies suggest that there is a high burden of psychiatric morbidity in people in prison, but, to our knowledge, the last published meta-analysis of prevalence is more than a decade old. We aimed to describe the pooled prevalence of depression, psychosis, bipolar disorder, and schizophrenia spectrum disorders for people who are incarcerated
-
Adverse childhood experiences in firstborns and mental health risk and health-care use in siblings: a population-based birth cohort study of half a million children in England Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Shabeer Syed, Laura D Howe, Rebecca E Lacey, Jessica Deighton, Muhammad Qummer ul Arfeen, Gene Feder, Ruth Gilbert
BackgroundAdverse childhood experiences (ACEs) often affect multiple children within families, yet studies tend to focus on the health outcomes of individual children, underestimating the needs of affected families. We aimed to examine the association between firstborns exposed to ACEs between 1 year before and 2 years after birth (the first 1000 days) and the risks of mental health problems, mental
-
Health benefits of leisure-time physical activity by socioeconomic status, lifestyle risk, and mental health: a multicohort study Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Solja T Nyberg, Philipp Frank, Jaana Pentti, Lars Alfredsson, Jenni Ervasti, Marcel Goldberg, Anders Knutsson, Aki Koskinen, Tea Lallukka, Maria Nordin, Ossi Rahkonen, Timo Strandberg, Sakari Suominen, Ari Väänänen, Jussi Vahtera, Marianna Virtanen, Hugo Westerlund, Marie Zins, Sari Stenholm, Séverine Sabia, Mika Kivimäki
BackgroundRegular physical activity is recommended for all aged 5 years and older, but the health benefits gained might differ across population subgroups. The aim of this study was to examine these benefits in terms of years lived free from major non-communicable diseases in subgroups with varying levels of risk factors. MethodsOur analysis was based on a multicohort study of initially healthy European
-
The adverse public health effects of non-medical cannabis legalisation in Canada and the USA Lancet Public Health (IF 25.4) Pub Date : 2025-02-03 Tesfa Mekonen Yimer, Eva Hoch, Benedikt Fischer, Danielle Dawson, Wayne Hall
Cannabis consumption is legally prohibited in most countries in the world. Several countries are legalising cannabis for adult consumption. It is important to monitor the public health effects of these policy changes. In this paper, we summarise the evidence to date on the legalisation of adult non-medical cannabis use in Canada and the USA. We describe regulatory models for cannabis legalisation,
-
Life expectancy by county and educational attainment in the USA, 2000–19: an observational analysis Lancet Public Health (IF 25.4) Pub Date : 2025-01-23
BackgroundEducational disparities in life expectancy in the USA have been documented nationally but have not been comprehensively explored at the county level. Such geographical granularity is necessary for determining how these disparities vary across the country, thus highlighting the populations that could benefit most from increased access to educational support. We aim to estimate life expectancy
-
Anyone can drown. No one should. Lancet Public Health (IF 25.4) Pub Date : 2025-01-02
“Anyone can drown. No one should.” notes WHO Director General Tedros Adhanom Ghebreyesus, in his foreword to the first WHO Global status report on drowning prevention, released on Dec 13, 2024. Following on from the recommendations of the UN resolution on drowning prevention, championed by the Governments of Bangladesh and Ireland and the 2023 World Health Assembly resolution on accelerating action
-
Mortality in survivors of adolescent and young adult cancer: progress and opportunities Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Michael E Roth, Amy M Berkman
Survivors of adolescent and young adult (AYA) cancer (ie, those aged 15 to 39 years at diagnosis) are a large and growing population. There are more than 2 million survivors of AYA cancer in the USA alone,1 and efforts targeted at reducing late morbidity and mortality are urgently needed. In The Lancet Public Health, Taylor Hughes and colleagues2 evaluate the risk of mortality after a diagnosis of
-
Overall and late mortality among 24 459 survivors of adolescent and young adult cancer in Alberta, Canada: a population-based cohort study Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Taylor Hughes, Ruth L Diaz, Sarah McKillop, Paul C Nathan, Miranda M Fidler-Benaoudia
BackgroundAdolescent and young adult (AYA) cancer survivors are at an increased risk of premature mortality due to their cancer and its treatment. Herein, we aimed to quantify the excess risks of mortality among AYA cancer survivors and identify target populations for intervention. MethodsThe Alberta AYA Cancer Survivor Study is a retrospective, population-based cohort of individuals diagnosed with
-
The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used over time and their modelled impact on the COVID-19 pandemic Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Steven Santos, Matthew Humbard, Anastasia S Lambrou, Gary Lin, Yamil Padilla, Jasmine Chaitram, Muktha S Natrajan, Hannah L Kirking, Sean Courtney, Kim Del Guercio, Seth Roberts, Fraser Gaspar, Michael F Iademarco, Joseph Hamel, Reynolds M Salerno
BackgroundRapid, accessible, and accurate testing was paramount to an effective US COVID-19 response. Federal partners supported SARS-CoV-2 testing scale-up through an interagency-coordinated approach that focused on expanding supply chains, research and development, validation, and improving patient access. We aimed to provide an overview of the federal efforts to scale up the testing response and
-
The public health risks of counterfeit pills Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Joseph Friedman, Daniel Ciccarone
Synthetic illicit drugs, such as nitazenes and fentanyls, are becoming commonplace in countries around the world, including in Europe, Australia, and Latin America, which raises concern for overdose crises like those seen in North America. An important dimension of the risk represented by synthetic drugs is the fact that they are increasingly packaged in counterfeit pill form. These pills—often indistinguishable
-
Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons Lancet Public Health (IF 25.4) Pub Date : 2024-12-16 Nadine Kronfli MD, Daniel J Bromberg MSc, Prof Hans Wolff MD, Linda Montanari MSc, Serheii Vasyliev MD, Prof Frederick L Altice MD
The 1990 resolution by the UN General Assembly committed member states to provide health-care equity for people in prison, who are included in the global goals to control HIV and eliminate hepatitis C virus (HCV) by 2030. WHO has set ambitious HCV elimination targets by including people who inject drugs (PWID), yet has not prioritised PWID who are incarcerated, a substantial population who have or
-
Early childhood adversity associated with high-intensity public service use Lancet Public Health (IF 25.4) Pub Date : 2024-12-13 Nicole Racine, Andrea Evans
Experiences of early childhood adversity are common, with 1 in 6 children having high levels of adversity in their childhood.1 These exposures have detrimental effects on children's health and developmental trajectories and are associated with poor physical and mental health outcomes across the life course.2 Individuals exposed to high levels of childhood adversity might require increased support and
-
Association between childhood adversity and use of the health, social, and justice systems in Denmark (DANLIFE): a nationwide cohort study Lancet Public Health (IF 25.4) Pub Date : 2024-12-13 Bertina Kreshpaj PhD, Leonie K Elsenburg PhD, Prof Signe Hald Andersen PhD, Tjeerd Rudmer De Vries PhD, Karsten Thielen PhD, Prof Naja Hulvej Rod DMSc
Childhood adversities can negatively affect health and social outcomes. We aimed to assess the association between adversity in childhood and use of public services in early adulthood across three systems: health, social welfare, and justice.
-
Inequities in access to assistive technology: a call for action Lancet Public Health (IF 25.4) Pub Date : 2024-12-12 Luc de Witte, Rosalie van der Vaart
Based on existing cross-sectional studies, case studies, and policy-related reports, experts in the field of assistive technology have long suspected that even in high-income countries such as England not everyone who could benefit from assistive technology has access to it, and that there are inequities in access. However, there was little concrete data on the extent of these gaps. Those data have
-
Demographic, socioeconomic, and social barriers to use of mobility assistive products: a multistate analysis of the English Longitudinal Study of Ageing Lancet Public Health (IF 25.4) Pub Date : 2024-12-12 Jamie Danemayer MSc, Mikaela Bloomberg PhD, Adam Mills MSc, Prof Cathy Holloway PhD, Prof Shereen Hussein PhD
Cross-sectional evidence suggests that access to essential mobility assistive products (MAPs) might be dependent on non-clinical factors. However, MAP use is better understood as a dynamic process wherein individuals pass through different states of MAP need and use. We aimed to test associations of demographic, socioeconomic, and social factors with transitions between MAP need and use states.
-
Public health in China: challenges and prospects Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 The Lancet Public Health
This December issue of The Lancet Public Health is our annual themed issue on public health in China. It is dedicated to the 1·4 billion people living in China and to the health-care workers, practitioners, and researchers whose work is featured in this issue and presented at The Lancet-Chinese Academy of Medical Sciences Conference held in Beijing on Nov 21–22. Nowadays, China faces four important
-
Integrating prevention and treatment: rethinking China's health financing Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Zhicheng Wang, Kit Yee Chan, Qianyi Xia, Jiantuo Yu, Minghui Ren
Preventive health measures offer superior economic returns compared with the ever-increasing costs of treating established diseases, which place unsustainable pressure on health systems. By reducing the incidence and severity of illness, prevention minimises health-care expenditure and maximises societal welfare by lowering the burden of disease. In China, the principle of making prevention a priority
-
Associations of long-term nitrogen dioxide exposure with a wide spectrum of diseases: a prospective cohort study of 0·5 million Chinese adults Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Xi Xia PhD, Xia Meng PhD, Cong Liu PhD, Yi Guo MPhil, Xinyue Li MPhil, Yue Niu PhD, Kin Bong Hubert Lam PhD, Neil Wright PhD, Christiana Kartsonaki DPhil, Yiping Chen DPhil, Ling Yang PhD, Huaidong Du PhD, Canqing Yu PhD, Dianjianyi Sun PhD, Prof Jun Lv PhD, Prof Junshi Chen MD, Xiaoming Yang PhD, Ruqin Gao MPhil, Prof Shaowei Wu PhD, Prof Haidong Kan PhD, Ka Hung Chan DPhil, Prof Liming Li PhD, Prof
Little evidence is available on the long-term health effects of nitrogen dioxide (NO2) in low-income and middle-income populations. We investigated the associations of long-term NO2 exposure with the incidence of a wide spectrum of disease outcomes, based on data from the China Kadoorie Biobank.
-
Changes in the epidemiology of under-5 mortality in China from 2016 to 2022: an observational analysis of population-based surveillance data Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Chunhua He MD, Leni Kang PhD, Yuxi Liu MD, Xue Yu MD, Qi Li MD, Prof Juan Liang MD, Prof Li Dai PhD, Prof Xiaohong Li PhD, Prof Yanping Wang MD, Prof Jun Zhu MD, Prof Hanmin Liu PhD
Sustainable Development Goal (SDG) 3.2 aims to end preventable deaths of newborns and children younger than 5 years. China's progress towards SDG 3.2 has not been evaluated on multiple dimensions. We aimed to assess mortality rates in children younger than 5 years (hereafter referred to as under-5 mortality) and to quantify preventable child mortality and geospatial and temporal trends in child mortality
-
Digital mental health: a potential opportunity to improve health equity in China Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Hao Fong Sit MSc, Prof Wen Chen PhD, Prof Dan Wu PhD MBBS, Yangmu Huang MD, Prof Dong (Roman) Xu PhD MPP, Prof Brian J Hall PhD
Mental health is an important public health issue in China, compounded by a shortage in psychiatric services. Against this backdrop, digital technologies could offer solutions. Digital mental health interventions use technologies, such as smartphone applications, to improve mental health outcomes. Although there has been a drastic increase in mental health mobile apps available in recent years, current
-
All-cause and cause-specific mortality inequalities between people with and without disability: a nationwide data linkage study in Australia Lancet Public Health (IF 25.4) Pub Date : 2024-12-03 Yi Yang PhD, Peter Summers Mbiostat, Zoe Aitken PhD, Prof Anne Kavanagh PhD, George Disney PhD
Without high-quality statistics on mortality inequalities, designing policies to improve the health of people with disability is challenging. We aim to quantify mortality inequalities experienced by people with disability in Australia.
-
Closing the mortality gap for people with disabilities Lancet Public Health (IF 25.4) Pub Date : 2024-12-03 Hannah Kuper, Sara Rotenberg
There are about 1·3 billion people with disability globally, and their higher mortality rates mean that they are dying about 14 years earlier than people without disability.1, 2 In this issue of The Lancet Public Health, Yi Yang and colleagues’ study3 adds to this literature. Using large-scale longitudinal data from 15 million Australians, they showed that people with disability have high inequalities—whether
-
Correction to Lancet Public Health 2024; 9: e295–305 Lancet Public Health (IF 25.4) Pub Date : 2024-11-26
Tetzlaff F, Sauerberg M, Grigoriev P, et al. Age-specific and cause-specific mortality contributions to the socioeconomic gap in life expectancy in Germany, 2003–21: an ecological study. Lancet Public Health 2024; 9: e295–305—In figure 1 of this Article, sex data were plotted incorrectly. This correction has been made as of Nov 25, 2024.
-
Control of childhood obesity and implications for policy in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Yanhui Dong PhD, Prof Changzheng Yuan ScD, Jiajia Dang, Xinli Song, Prof Guo Cheng, Prof Yajun Chen, Prof Haijun Wang, Prof Jie Mi, Prof Bo Xi, Prof Yi Song PhD
Prevention and control of childhood obesity in China is complex. Despite numerous existing policy endeavours, particularly Healthy China 2030, accompanied by multiministerial initiatives, childhood obesity persists and even exacerbates. In this paper, we review current national policies, assess progress of the existing system managing childhood weight, and identify implementation challenges. Leveraging
-
Public health interventions against childhood obesity in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Changzheng Yuan ScD, Prof Yanhui Dong PhD, Hui Chen MS, Prof Le Ma PhD, Prof Lihong Jia PhD, Prof Jiayou Luo PhD, Prof Qin Liu PhD, Prof Yifei Hu PhD, Prof Jun Ma PhD, Prof Yi Song PhD
China is confronted with the challenge of increasing childhood obesity. Although interventions for childhood obesity have been developed, their effectiveness and implementation can vary considerably across nations. In this paper, we review and consolidate the evidence on childhood obesity intervention strategies aimed at multiple levels and components across life, in China. School-based interventions
-
Determinants of childhood obesity in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Changzheng Yuan ScD, Prof Yanhui Dong PhD, Hui Chen MS, Prof Le Ma PhD, Prof Lihong Jia PhD, Prof Jiayou Luo PhD, Prof Qin Liu PhD, Prof Yifei Hu PhD, Prof Jun Ma PhD, Yi Song PhD
Over the past four decades, China has witnessed an important nutritional transition, characterised by a heightened overnutrition burden among children. The country now has the largest population of children with obesity globally. In this paper, we review the epidemiology of childhood obesity in China, its determinants, and risk factors, with a particular focus on school-aged children. Evidence unveils
-
Obesity in China: what we know and what we can do Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Xiong-Fei Pan, Zhong-Ze Fang
Overweight and obesity in children have emerged as a major public health challenge in China. National statistics show that the prevalence of overweight and obesity reached up to 10% in children younger than 6 years and 20% in those aged 6–17 years,1 which is projected to continue rising in the next few years.2 In response to this public health imperative, 16 Chinese national agencies, including the
-
Diabetes in China part 1: epidemiology and risk factors Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Yu Xu PhD, Prof Jieli Lu MD, Mian Li PhD, Prof Tiange Wang PhD, Kan Wang PhD, Qiuyu Cao PhD, Yi Ding MD, Yu Xiang PhD, Siyu Wang BS, Qianqian Yang MS, Xuan Zhao BS, Xiaoyun Zhang MD, Prof Min Xu PhD, Prof Weiqing Wang MD, Prof Yufang Bi MD, Prof Guang Ning MD
The prevalence of diabetes in China is rapidly increasing. China now has the largest number of people living with diabetes worldwide, accounting for approximately one-quarter of the global diabetes population. Since the late 1970s, China has experienced profound changes and rapid economic growth, leading to shifts in lifestyle. Changing dietary patterns, reduced physical activity, and stress have contributed
-
Diabetes in China part 2: prevention, challenges, and progress Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Yu Xu PhD, Prof Jieli Lu MD, Mian Li PhD, Prof Tiange Wang PhD, Kan Wang PhD, Qiuyu Cao PhD, Yi Ding MD, Yu Xiang PhD, Siyu Wang BS, Qianqian Yang MS, Xuan Zhao BS, Xiaoyun Zhang MD, Prof Min Xu PhD, Prof Weiqing Wang MD, Prof Yufang Bi MD, Prof Guang Ning MD
During the past 40 years, the prevalence of diabetes in China has increased from less than 1·0% in 1980 to 12·4% in 2018, an increase in line with the rapid growth of the nation's economy. To address such a burden, the Healthy China 2030 initiative and subsequent Action Plan, including a diabetes prevention and control campaign, were launched. A shift from a disease-centred approach to a health-centred
-
Implementing comprehensive nationwide smoke-free legislation in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-19 Shiwei Liu, Zhuo Chen
Tobacco use is the leading cause of preventable death globally, accounting for more than 7 million deaths worldwide, including nearly 1·3 million deaths due to second-hand smoke.1 There is no safe threshold of exposure to second-hand smoke, and smoke-free environments are a proven way to adequately protect people from the harmful effects of second-hand smoke without harming businesses.2 Legislation
-
Effects of comprehensive smoke-free legislation on smoking behaviours and macroeconomic outcomes in Shanghai, China: a difference-in-differences analysis and modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-11-19 Hongqiao Fu PhD, Sian Tsuei PhD, Yunting Zheng PhD, Simiao Chen ScD, Shirui Zhu MSc, Duo Xu PhD, Prof Winnie Yip PhD
China has one of the highest levels of tobacco consumption globally, and there is no national smoke-free legislation. Although more than 20 Chinese cities have passed local smoke-free laws since 2008, evidence on their effectiveness in reducing smoking behaviours and their economic benefits is scarce. By exploiting a natural quasi-experiment, whereby a comprehensive public smoking ban was implemented
-
Correction to Lancet Public Health 2024; 9: e834–35 Lancet Public Health (IF 25.4) Pub Date : 2024-11-04
Tan M. Mandatory salt targets: a key policy tool for global salt reduction efforts. Lancet Public Health 2024; 9: e834–35—In this Linked Comment, the fifth sentence of the third paragraph should have said US$8·0 billion. This correction has been made as of Nov 4, 2024.
-
The 2024 China report of the Lancet Countdown on health and climate change: launching a new low-carbon, healthy journey Lancet Public Health (IF 25.4) Pub Date : 2024-11-04 Prof Wenjia Cai PhD, Prof Chi Zhang PhD, Shihui Zhang PhD, Prof Yuqi Bai PhD, Max Callaghan PhD, Nan Chang BM, Prof Bin Chen PhD, Huiqi Chen BM, Liangliang Cheng PhD, Prof Hancheng Dai PhD, Prof Weicheng Fan PhD, Prof Dabo Guan PhD, Yixin Hu PhD, Yifan Hu BS, Junyi Hua PhD, Prof Cunrui Huang PhD, Prof Hong Huang PhD, Jianbin Huang PhD, Prof Xiaomeng Huang PhD, John S Ji Dsc, Qiaolei Jiang PhD, Xiaopeng
2023 was a landmark year for climate change globally, across Asia, and within China. Global average temperatures were 1·45°C higher than the pre-industrial average, making it the warmest year on record since 1850. In Asia, 2023 was the second-hottest year documented. China recorded its highest-ever average temperature at 10·71°C (0·82°C above the 1981–2010 average), had its second-lowest rainfall since
-
Estimated health benefits, costs, and cost-effectiveness of implementing WHO's sodium benchmarks for packaged foods in India: a modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Kathy Trieu PhD, Liping Huang PhD, Leopold N Aminde PhD, Linda Cobiac PhD, Daisy H Coyle PhD, Mary Njeri Wanjau PhD, Sudhir Raj Thout MA, Prof Bruce Neal PhD, Prof Jason H Y Wu PhD, Prof Lennert Veerman PhD, Matti Marklund PhD, Rachita Gupta PhD
Excess dietary sodium intake has been associated with death and disability. WHO has released global sodium benchmarks for packaged foods to support countries to reduce population sodium intake. This study aimed to assess the potential health effect, costs, and cost effectiveness of implementing these WHO sodium benchmarks in India.
-
Mandatory salt targets: a key policy tool for global salt reduction efforts Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Monique Tan
Salt is consumed in excess in most countries, with global salt intake averaging at more than double the recommended maximum limit of 5 g per day. By raising blood pressure, excess salt intake is a major risk factor for cardiovascular disease, the leading cause of premature death and ill health worldwide. In 2013, all WHO Member States committed to a 30% reduction in average salt intake by 2025. However
-
Contemporary heart failure and comorbidity risk management Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Meng Li, Gregory Y H Lip
Heart failure is a global health burden, with an estimated prevalence of more than 56 million individuals worldwide.1 Notably, heart failure is highly associated with poor quality of life, frequent admissions to hospital, rising health-care costs, and high mortality rates. This complex clinical syndrome poses challenges to therapeutic interventions of heart failure, especially since a higher comorbidity
-
Implementation efforts to support transition to HPV-based cervical cancer screening Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Maribel Almonte, María de la Luz Hernández, Prajakta Adsul
On average, it takes 15 years from the landmark publication on a cancer control evidence-based intervention to achieve 50% uptake in routine practice.1 In fact, nearly 20 years have passed since the first observational studies showed that human papillomavirus (HPV) DNA testing had substantially higher sensitivity for detecting cervical precancer and cancer compared with cervical cytology.2 Since then
-
Estimated health effect, cost, and cost-effectiveness of mandating sodium benchmarks in Australia's packaged foods: a modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Matti Marklund PhD, Kathy Trieu PhD, Leopold N Aminde MD, Linda Cobiac PhD, Daisy H Coyle PhD, Liping Huang PhD, Prof Bruce Neal PhD, Prof Lennert Veerman MD, Prof Jason H Y Wu PhD
Excess dietary sodium is a leading cause of death and disability globally. Because packaged foods are a major source of sodium in many countries, including Australia, mandatory limits for sodium might improve population health. We aimed to estimate the long-term health and economic effect of mandating such thresholds in Australia.
-
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Robert A Fletcher MSc, Patrick Rockenschaub PhD, Brendon L Neuen PhD, Isabel Johanna Walter MD, Nathalie Conrad DPhil, Mehrdad A Mizani PhD, Thomas Bolton PhD, Claire A Lawson PhD, Christopher Tomlinson MBBS, Stelios Boulitsakis Logothetis MEng, Carmen Petitjean MPhil, Luigi Filippo Brizzi MD, Stephen Kaptoge PhD, Elena Raffetti PhD, Patrick A Calvert PhD, Prof Emanuele Di Angelantonio FMedSci, Prof
Heart failure is common, complex, and often associated with coexisting chronic medical conditions and a high mortality. We aimed to assess the epidemiology of people admitted to hospital with heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), including the period covering the COVID-19 pandemic, which was previously not well characterised
-
Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Jiangrong Wang PhD, K Miriam Elfström PhD, Prof Joakim Dillner MD
Human papillomavirus (HPV)-based cervical screening is a globally recommended public health policy. Randomised clinical trials find superior performance of primary HPV-based screening compared with cytology for preventing cervical cancer. However, additional evidence from real-world public health policies is needed. In preplanned secondary analysis of a randomised health-care policy trial in Sweden
-
City mobility patterns during the COVID-19 pandemic: analysis of a global natural experiment Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Prof Ruth F Hunter PhD, Selin Akaraci PhD, Ruoyu Wang PhD, Prof Rodrigo Reis PhD, Prof Pedro C Hallal PhD, Prof Sandy Pentland PhD, Prof Christopher Millett PhD, Leandro Garcia PhD, Jason Thompson PhD, Kerry Nice PhD, Belen Zapata-Diomedi PhD, Prof Esteban Moro PhD
During the COVID-19 pandemic, changes were seen in city mobility patterns around the world, including in active transportation (walking, cycling, micromobility, and public transit use), creating a unique opportunity for global public health lessons and action. We aimed to analyse a global natural experiment exploring city mobility patterns during the pandemic and how they related to the implementation
-
Alcohol and mortality in Mexico: prospective study of 150 000 adults Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Eirini Trichia PhD, Prof Jesus Alegre-Díaz MD, Diego Aguilar-Ramirez DPhil, Raúl Ramirez-Reyes, Adrián Garcilazo-Ávila PhD, Carlos González-Carballo MSc, Fiona Bragg DPhil, Louisa Gnatiuc Friedrichs DPhil, Prof William G Herrington MD, Lisa Holland PhD, Jason Torres PhD, Rachel Wade MSc, Prof Rory Collins FRS, Prof Richard Peto FRS, Prof Jaime Berumen PhD, Prof Roberto Tapia-Conyer PhD, Prof Pablo
Alcohol consumption is a leading cause of premature death globally, but there is no large-scale prospective evidence from Mexico.
-
50 years of comprehensive state-wide data on pregnancy termination in South Australia: a retrospective, population-based, cohort study Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Laura J Slade MWomHMed, Jennie Louise PhD, Prof Katina D’Onise PhD, Prof Jodie M Dodd PhD
Termination of pregnancy is a common procedure, accessed globally, irrespective of logistical and legal barriers. We aimed to document changes in procedural characteristics and demographic factors over time in South Australia, as well as to examine how key sociodemographic variables affect gestational age at pregnancy termination.
-
Workplace mortality risk and social determinants among migrant workers: a systematic review and meta-analysis Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Karen Lau MSc, Prof Robert Aldridge PhD, Prof Marie Norredam PhD, George Frederick Mkoma PhD, Mathura Kugan MSc, Rosita Chia-Yin Lin MSc, Ligia Kiss PhD, Prof Cathy Zimmerman PhD, Prof Sally Hargreaves PhD
Migrant workers, a population of 170 million, often work in dangerous or unhealthy working environments and are likely to suffer workplace injuries and labour abuses. However, the risk of mortality in migrant workers compared with local workers is unknown. We aim to synthesise global evidence on migrant worker mortality risk and identify social determinants to inform health and safety protections for
-
Trends and inequalities in thinness and obesity among Chinese children and adolescents: evidence from seven national school surveys between 1985 and 2019 Lancet Public Health (IF 25.4) Pub Date : 2024-10-29 Xinli Song PhD, Bin Zhou PhD, Prof Sarah Baird PhD, Prof Chunling Lu PhD, Prof Majid Ezzati PhD, Li Chen PhD, Jieyu Liu PhD, Yi Zhang MS, Ruolin Wang MS, Qi Ma MS, Jianuo Jiang MS, Yang Qin MS, Ziqi Dong MS, Wen Yuan PhD, Tongjun Guo PhD, Zhiying Song PhD, Yunfei Liu PhD, Jiajia Dang PhD, Peijin Hu PhD, Prof Yanhui Dong PhD, Prof Yi Song PhD, Prof Jun Ma PhD, Prof Susan M Sawyer MD
There are little recent data in China regarding contemporary nutritional inequities among children and adolescents, particularly in relation to urban–rural residence and regional socioeconomic status (SES). We aim to assess inequalities in thinness and obesity in Chinese children and adolescents.
-
Time for a public health response to gambling Lancet Public Health (IF 25.4) Pub Date : 2024-10-24 The Lancet Public Health
Today, we publish the Lancet Public Health Commission on gambling—an inquiry and response to a neglected, understudied, and expanding public health threat. Gambling is not a simple leisure activity; it is a health-harming addictive behaviour. The harms associated with gambling are wide-ranging, not only affecting an individual's health and wellbeing, but also their wealth and relationships, affecting
-
The Lancet Public Health Commission on gambling Lancet Public Health (IF 25.4) Pub Date : 2024-10-24 Prof Heather Wardle PhD, Prof Louisa Degenhardt PhD, Virve Marionneau PhD, Prof Gerda Reith PhD, Charles Livingstone PhD, Prof Malcolm Sparrow PhD, Lucy T Tran MSc, Blair Biggar PhD, Prof Christopher Bunn PhD, Prof Michael Farrell PhD, Viktorija Kesaite PhD, Vladimir Poznyak MD, Jianchao Quan MD, Prof Jürgen Rehm PhD, Angela Rintoul PhD, Prof Manoj Sharma PhD, Prof Jeremy Shiffman PhD, Kristiana Siste
The global gambling industry is rapidly expanding, with net losses by consumers projected to reach nearly US$700 billion by 2028. Industry growth is fuelled by the rise of online gambling, widespread accessibility of gambling opportunities through mobile phones, increased legalisation, and the introduction of commercial gambling to new areas. Recent expansion is most notable in low-income and middle-income
-
Cancer risk and legalisation of access to cannabis in the USA: overview of the evidence Lancet Public Health (IF 25.4) Pub Date : 2024-10-18 Nigar Nargis, J Lee Westmaas, Eva Orr, Mohammed M Alqahtani, Parichoy Pal Choudhury, Farhad Islami, Ahmedin Jemal
Cannabis in the USA is transitioning from a nationwide illegal status to liberalisation for medicinal or recreational use across different jurisdictions. As the acceptability and accessibility of cannabis continue to grow, updated knowledge on the cancer risk from recreational cannabis use is necessary to inform recommendations by public health organisations, policy makers, and clinical practitioners